Moderna Issues $2 Billion Zero-Coupon Convertible Debt Offering

Pharmaceutical developer Moderna plans to raise $2 billion through zero-coupon convertible notes, with analysts debating whether capped call strategies will adequately mitigate shareholder dilution. The move signals the company's focus on funding pipeline development without immediate cash interest burdens.